Gregory Behbehani, MD, PhDThe James Cancer Center
- Acute Myeloid Leukemias
- Molecular Biology
I’m a hematologist-oncologist and provide clinical, inpatient care of patients with acute myeloid leukemia and acute lymphocytic leukemia. I also serve as an assistant professor of internal medicine at The Ohio State University.
I received my medical training at the University of Cincinnati, where I also earned a PhD in molecular genetics. I completed a fellowship in hematology and oncology at Stanford University, where I later completed a postdoctoral fellowship in the laboratory of Garry Nolan focusing on applying mass cytometry (CyTOF) to the characterization of clinical samples from patients with hematologic malignancies.
My research laboratory at The Ohio State University is focused on using the single-cell deep functional phenotyping enabled by mass cytometry. That helps predict how novel therapeutic approaches might be optimally combined with current therapies to prevent treatment failures.
The collegial, caring atmosphere at the OSUCCC – James makes this not only a wonderful place to work but a great place to receive treatment, too. Our multidisciplinary approach, combined with state-of-the-art science, helps patients have more efficient, targeted treatment and better outcomes.
Education and Background
University of Cincinnati
Stanford Hospital and Clinics
Palo Alto, CA
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Hematology)
- American Board of Internal Medicine (Subspecialty: Medicine Oncology)
- Department of Internal Medicine
- Division of Hematology
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Behbehani has reported no financial relationships with medical device, research and/or drug companies.